FPP
WST icon

Findlay Park Partners’s West Pharmaceutical WST Stock Holding History

Findlay Park Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214M Sell
596,646
-20,120
-3% -$6.15M 2.89% 10
2026
Q1 		$155M Sell
616,766
-50,160
-8% -$12.5M 2.15% 18
2025
Q4 		$183M Sell
666,926
-135,180
-17% -$37M 2.34% 16
2025
Q3 		$210M Sell
802,106
-14,500
-2% -$3.52M 2.21% 16
2025
Q2 		$179M Sell
816,606
-29,600
-3% -$6.33M 1.84% 22
2025
Q1 		$189M Buy
846,206
+11,500
+1% +$3.17M 1.95% 21
2024
Q4 		$273M Buy
834,706
+7,000
+0.8% +$2.2M 2.72% 9
2024
Q3 		$248M Buy
827,706
+85,800
+12% +$26.3M 2.34% 11
2024
Q2 		$244M Buy
741,906
+144,800
+24% +$51.2M 2.3% 19
2024
Q1 		$236M Buy
597,106
+139,800
+31% +$51.7M 2.17% 18
2023
Q4 		$161M Buy
457,306
+180,415
+65% +$63.8M 1.58% 27
2023
Q3 		$104M Sell
276,891
-2,611
-0.9% -$1.01M 1.12% 40
2023
Q2 		$107M Sell
279,502
-17,538
-6% -$6.27M 1.1% 43
2023
Q1 		$103M Buy
297,040
+125,138
+73% +$36.6M 1.09% 42
2022
Q4 		$40.5M Buy
+171,902
New +$40.7M 0.44% 46

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Findlay Park Partners's WST Position: Q2 2026 in Review

Findlay Park Partners reduced its West Pharmaceutical (WST) stake by 3.3% in Q2 2026, selling an estimated $6.15M and leaving 596,646 shares worth $214M. The position accounts for 2.89% of the portfolio, ranked #10.

Findlay Park Partners first reported a position in WST in Q4 2022 and has held it in 15 quarters since. The position peaked at $273M in Q4 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Findlay Park Partners held 596,646 shares of West Pharmaceutical worth $214M as of Q2 2026.
  • Findlay Park Partners sold 20,120 West Pharmaceutical shares in Q2 2026, an estimated $6.15M.
  • West Pharmaceutical made up 2.89% of Findlay Park Partners's portfolio in Q2 2026, its #10 holding.
  • Findlay Park Partners first reported a position in West Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • Findlay Park Partners's West Pharmaceutical position peaked at $273M in Q4 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Findlay Park Partners's 13F filing for Q2 2026, filed 12 Aug 2026.